MedPath

Evaluation of the efficacy and safety of the drugs Pyronaridine-Artesunate (Pyramax™) and Primaquine to treat uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Salavanh province, Lao PDR

Phase 4
Conditions
Malaria
Registration Number
ACTRN12618001348246
Lead Sponsor
Ministry of Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath